Cisco warns of pharma malware threat; Celgene invests in Venter's Human Longevity;

> Cisco found pharma was one of the industries most exposed to malware in the first half of 2014. Article

> Celgene ($CELG) invested in J. Craig Venter's Human Longevity as part of a partnership deal. News

> Certara added suggested synthesis steps to its drug candidate design software. Release

> Huron Consulting began offering a clinical trial data analytics and visualization service. Item

> An academic analyzed the threats posed by possible breaches of biological databases. Feature

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.